Clinical Trial Detail

NCT ID NCT03657641
Title Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors University of Southern California
Indications

colorectal cancer

Therapies

Pembrolizumab + Regorafenib

Age Groups: adult senior

No variant requirements are available.